FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula (1) in which the radicals and symbols have the meanings indicated in the claims and to pharmaceutically acceptable salts thereof. Compounds of formula (1) are ERK inhibitors.
.
EFFECT: invention also relates to a pharmaceutical composition comprising and to methods for treating malignant neoplasms using a compound of formula (1).
16 cl, 6 tbl, 458 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HETEROCYCLIC AMINES AND THEIR APPLICATION | 2011 |
|
RU2632900C2 |
| KINASE INHIBITORS | 2012 |
|
RU2623734C9 |
| CYCLOALKYL NITRILE PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2655380C2 |
| NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITING NAMPT | 2011 |
|
RU2617424C2 |
| PESTICIDAL COMPOSITIONS AND METHODS RELATED THERETO | 2013 |
|
RU2627654C2 |
| THERAPEUTIC COMPOUNDS AND COMPOSITIONS | 2015 |
|
RU2733405C2 |
| PYRAZOLOPYRIMIDINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1993 |
|
RU2124016C1 |
| N-(2-CYANO HETEROCYCLYL)PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2669922C2 |
| GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2664533C2 |
| MULTISUBSTITUTED AROMATIC COMPOUNDS AS SERINE PROTEASE INHIBITORS | 2014 |
|
RU2678830C2 |
